UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
AbbVie says its psoriasis drug superior to Novartis’ treatment
by Lee Han-soo
2020-01-17 17:28
HanAll, Daewoong unveil P3 topline results for dry eye treatment
by Lee Han-soo
2020-01-16 15:46
Genome to conduct immunotherapy combo trial with Merck, Pfizer
by Lee Han-soo
2020-01-16 14:47
GSK to target ovarian cancer, multiple myeloma, endometrial cancer
by Kim Yun-mi
2020-01-16 14:10
Sweden prolongs financial support for IVI’s vaccine development
by Lee Han-soo
2020-01-16 10:45
라인
Pharmaceutical association lays out plans for 2020
by Lee Han-soo
2020-01-15 14:29
AptaBio attending J.P. Morgan event for global collaboration
by Shim Hyun-tai
2020-01-15 13:06
GC Pharma's US offshoot opens new plasma center
by Shim Hyun-tai
2020-01-15 13:05
Jeil, Oncocross to discover new indications for stroke therapy
by Lee Han-soo
2020-01-15 11:31
Will Steglatro prove SGLT-2 inhibitor’s cardiovascular benefits?
by Kim Yun-mi
2020-01-14 15:28
라인
Genexine becomes largest shareholder of GenNBio
by Lee Han-soo
2020-01-14 11:11
Daewoong, A2A to develop AI-based anticancer treatment
by Lee Han-soo
2020-01-14 10:35
GSK shows meaningful response rate for treatment of multiple myeloma
by Lee Han-soo
2020-01-13 17:48
Zejula widens indication as monotherapy for ovarian cancer
by Kim Yun-mi
2020-01-13 16:25
Vivozon positive of Opiranserin’s efficacy despite failures to meet primary endpoint
by Lee Han-soo
2020-01-13 16:22
라인
Lilly secures atopic dermatitis drug through Dermira acquisition
by Kim Yun-mi
2020-01-13 14:05
Latecomer Bavencio improves overall survival in bladder cancer trial
by Kim Yun-mi
2020-01-10 14:23
HLB gets UAE’s nod for joint company with local partner
by Lee Han-soo
2020-01-08 16:31
Daewoong, Avacta to establish joint venture
by Lee Han-soo
2020-01-08 12:25
Genexine licenses out immunosuppressant candidate to GenNBio
by Lee Han-soo
2020-01-07 17:35
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top